Skip to Main Content

Paper Details

Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma.
Oncotarget
14
2016
AGAP2, CDK4, CLDN12, CNV, CPM, DCUN1D2, GAS6, GBM, GTPBP10, LAMP1, LANCL2, PDLIM1, TSPAN33, glioblastoma, multicentric GBM, multicentric glioblastoma, multicentric tumor, patient, patients, solitary GBM, solitary tumors, tumor
Adult, Aged, Brain Neoplasms, Female, Gene Dosage, Genomics, Glioblastoma, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Phenotype, Prognosis, Retrospective Studies, Transcriptome
Author NameAffiliation
Doo-Sik KongSamsung Medical Center, Sungkyunkwan University School of Medicine
Doo-Sik KongSamsung Advanced Institute of Technology, Samsung Electronics Co.
Doo-Sik KongInstitute for Refractory Cancer Research, Samsung Medical Center
Doo-Sik KongSamsung Biomedical Research Institute, Samsung Medical Center
Doo-Sik KongSamsung Medical Center, Sungkyunkwan University School of Medicine
Doo-Sik KongSamsung Biomedical Research Institute, Samsung Medical Center
Doo-Sik KongInstitute for Refractory Cancer Research, Samsung Medical Center
Doo-Sik KongSamsung Advanced Institute of Technology, Samsung Electronics Co.
Jinkuk KimSamsung Biomedical Research Institute, Samsung Medical Center
Jinkuk KimSamsung Advanced Institute of Technology, Samsung Electronics Co.
Jinkuk KimInstitute for Refractory Cancer Research, Samsung Medical Center
Jinkuk KimSamsung Biomedical Research Institute, Samsung Medical Center
Jinkuk KimInstitute for Refractory Cancer Research, Samsung Medical Center
Jinkuk KimSamsung Advanced Institute of Technology, Samsung Electronics Co.
In-Hee LeeSamsung Biomedical Research Institute, Samsung Medical Center
In-Hee LeeSamsung Advanced Institute of Technology, Samsung Electronics Co.
In-Hee LeeInstitute for Refractory Cancer Research, Samsung Medical Center
In-Hee LeeSamsung Biomedical Research Institute, Samsung Medical Center
In-Hee LeeInstitute for Refractory Cancer Research, Samsung Medical Center
In-Hee LeeSamsung Advanced Institute of Technology, Samsung Electronics Co.
Sung Tae KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Sung Tae KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Ho Jun SeolSamsung Medical Center, Sungkyunkwan University School of Medicine
Ho Jun SeolSamsung Medical Center, Sungkyunkwan University School of Medicine
Jung-Il LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Jung-Il LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Woong-Yang ParkSamsung Genome Institute, Samsung Medical Center
Woong-Yang ParkSamsung Genome Institute, Samsung Medical Center
Gyu Ha RyuIcahn School of Medicine at Mount Sinai
Gyu Ha RyuIcahn School of Medicine at Mount Sinai
Zichen WangIcahn School of Medicine at Mount Sinai
Zichen WangIcahn School of Medicine at Mount Sinai
Avi Ma'ayanIcahn School of Medicine at Mount Sinai
Avi Ma'ayanIcahn School of Medicine at Mount Sinai
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamSamsung Biomedical Research Institute, Samsung Medical Center
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSamsung Advanced Institute of Technology, Samsung Electronics Co.
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamSamsung Biomedical Research Institute, Samsung Medical Center
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSamsung Advanced Institute of Technology, Samsung Electronics Co.
  • 1 - 42

Datasets

Release 1.2